1720 — Standard Chem & Pharm Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD11.56bn
- TWD13.36bn
- TWD6.24bn
- 89
- 60
- 87
- 95
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,692 | 1,481 | 2,989 | 2,599 | 2,276 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 916 | 967 | 1,490 | 1,480 | 1,419 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,614 | 3,602 | 5,784 | 5,589 | 5,418 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,388 | 2,447 | 3,095 | 4,109 | 4,359 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,928 | 7,049 | 10,095 | 10,968 | 11,189 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,813 | 1,651 | 2,716 | 2,880 | 2,371 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,164 | 3,084 | 5,753 | 6,215 | 5,890 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 3,764 | 3,966 | 4,342 | 4,753 | 5,299 |
Total Liabilities & Shareholders' Equity | 6,928 | 7,049 | 10,095 | 10,968 | 11,189 |
Total Common Shares Outstanding |